ADRIAN BATES: Open Payments
NPI 1497363345 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 40 payments from 10 companies in 2025. Trend: 2023 $907 · 2024 $482 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $225 |
| Vanda Pharmaceuticals Inc. | 7 | $158 |
| Janssen Pharmaceuticals, Inc | 2 | $138 |
| Alkermes, Inc. | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| ABBVIE INC. | 3 | $46 |
| Indivior Inc. | 1 | $33 |
| Braeburn Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: REXULTI, INVEGA SUSTENNA, FANAPT, ARISTADA, HETLIOZ, ABILIFY MAINTENA, COBENFY, VRAYLAR.
Industry payments across OH — which companies pay providers there.
